VYTELO

Serial Number 90658694
606

Registration Progress

Application Filed
Apr 20, 2021
Under Examination
May 3, 2022
Approved for Publication
Mar 8, 2022
Published for Opposition
Mar 8, 2022
Registered

Trademark Image

VYTELO

Basic Information

Serial Number
90658694
Filing Date
April 20, 2021
Published for Opposition
March 8, 2022
Abandonment Date
December 9, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 9, 2024
Classes
005

Rights Holder

Geron Corporation

03
Address
919 E. Hillsdale Blvd., Suite 250
Foster City, CA 94404

Ownership History

Geron Corporation

Original Applicant
03
Foster City, CA

Geron Corporation

Owner at Publication
03
Foster City, CA

Legal Representation

Attorney
Sharon R. Smith

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

35 events
Date Code Type Description Documents
Dec 9, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 9, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Apr 17, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 16, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 16, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 16, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 12, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 10, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 10, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 10, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 9, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 7, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 7, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 7, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 15, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 15, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 15, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 28, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 26, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 26, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 26, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 3, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 8, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 8, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 16, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 27, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 20, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 20, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 20, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 13, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 13, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 13, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 13, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 28, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 23, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceuticals for the treatment, diagnosis or prophylaxis of human diseases, disorders and conditions, namely, cancer, and diseases, disorders and conditions of the hematological systems

Classification

International Classes
005